While historically, the process of tumorigenesis in humans was considered to result from the sequential accumulation of inherited and/or somatic mutations within the 'tumor cell '(71),it is clear that the stroma is an integral part of the tumor and that it contributes to some of the most destructive characteristics of malignant cells. Understanding the genetic aberrations that occur in both tumor cells and stromal cells, and elucidating the details of the molecular pathways that are altered as a result of these aberrations, will be key to our overall understanding of human cancer. Uncontrolled cell proliferation is one of the hallmarks of cancer, and both epithelial tumor cells and stromal fibroblast cells have acquired genetic and/or epigenetic changes to genes that directly regulate their cell cycles. Entry into the cell cycle and stimulation of cell proliferation involves the induction of immediate early gene products such as Myc as well as the activation of the Rb pathway that is critical for G1 to S phase progression. Our recent studies demonstrate that E2F1, E2F2 and E2F3 mediate Rb function in vivo and that these three activities are essential components in the Myc pathway that controls cell proliferation and cell fate decisions of both epithelial and stromal fibroblasts. We entertain the hypothesis that the microenvironment of a given tissue is strongly influenced by the function of Rb, and inactivation of this tumor suppressor pathway within stromal fibroblasts contributes strongly to the evolution of neoplasm. The proposed studied will employ transgenic and conditional gene knock-out strategies in order to address the following three specific aims:
Specific Aim 1 : To examine the role of tumor suppressor and oncogenic pathways, operating within mammary stromal fibroblasts, on the proliferation of normal epithelial cells.
Specific Aim 2 : To examine the role of tumor suppressor and oncogenic pathways, operating within mammary stromal fibroblasts, in moderating the tumorigenicity of oncogene-primed epithelial cells.
Specific Aim 3 : To assess in vivo the contributions made by Rb within mammary stromal fibroblasts, towards the development of Myc-induced mammary epithelial tumors

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
1P01CA097189-01A2
Application #
6995150
Study Section
Subcommittee G - Education (NCI)
Project Start
2004-09-15
Project End
2009-07-31
Budget Start
2004-09-15
Budget End
2005-07-31
Support Year
1
Fiscal Year
2004
Total Cost
$204,006
Indirect Cost
Name
Ohio State University
Department
Type
DUNS #
832127323
City
Columbus
State
OH
Country
United States
Zip Code
43210
Sizemore, Steven T; Mohammad, Rahman; Sizemore, Gina M et al. (2018) Synthetic Lethality of PARP Inhibition and Ionizing Radiation is p53-dependent. Mol Cancer Res 16:1092-1102
Pitarresi, Jason R; Liu, Xin; Avendano, Alex et al. (2018) Disruption of stromal hedgehog signaling initiates RNF5-mediated proteasomal degradation of PTEN and accelerates pancreatic tumor growth. Life Sci Alliance 1:e201800190
Ahirwar, Dinesh K; Nasser, Mohd W; Ouseph, Madhu M et al. (2018) Fibroblast-derived CXCL12 promotes breast cancer metastasis by facilitating tumor cell intravasation. Oncogene 37:4428-4442
Rudolph, M; Sizemore, S T; Lu, Y et al. (2018) A hedgehog pathway-dependent gene signature is associated with poor clinical outcomes in Luminal A breast cancer. Breast Cancer Res Treat 169:457-467
Sizemore, Gina M; Balakrishnan, Subhasree; Thies, Katie A et al. (2018) Stromal PTEN determines mammary epithelial response to radiotherapy. Nat Commun 9:2783
Victor, Aaron R; Nalin, Ansel P; Dong, Wenjuan et al. (2017) IL-18 Drives ILC3 Proliferation and Promotes IL-22 Production via NF-?B. J Immunol 199:2333-2342
Liu, Huayang; Dowdle, James A; Khurshid, Safiya et al. (2017) Discovery of Stromal Regulatory Networks that Suppress Ras-Sensitized Epithelial Cell Proliferation. Dev Cell 41:392-407.e6
Tang, Xing; Srivastava, Arunima; Liu, Huayang et al. (2017) annoPeak: a web application to annotate and visualize peaks from ChIP-seq/ChIP-exo-seq. Bioinformatics 33:1570-1571
Sizemore, G M; Balakrishnan, S; Hammer, A M et al. (2017) Stromal PTEN inhibits the expansion of mammary epithelial stem cells through Jagged-1. Oncogene 36:2297-2308
Hammer, Anisha M; Sizemore, Gina M; Shukla, Vasudha C et al. (2017) Stromal PDGFR-? Activation Enhances Matrix Stiffness, Impedes Mammary Ductal Development, and Accelerates Tumor Growth. Neoplasia 19:496-508

Showing the most recent 10 out of 89 publications